StockData
BeOne Medicines Ltd. logo

BeOne Medicines Ltd.

ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$361.27−9.06 (-2.45%)

Close on Nov 2, 2026Market cap $41.08BP/E 64.6Yield –

BeOne Medicines Deferred Income Tax Liabilities, Net by Year

Deferred Income Tax Liabilities, Net ($M) ($M)

BeOne Medicines Deferred Income Tax Liabilities, Net: $53.2M in FY2025, up 26.7% from a year earlier. That is the highest of the 9 years on record here.

Latest, FY2025
53.2
Period ended Dec 31, 2025
Change on a year earlier
+26.7%
42 in FY2024
History
9 years
Since FY2017
Sources
9
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-Q (filed 2026-08-05) ↗

Reported in Form 10-Q / 10-K Income Taxes Note (XBRL).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedDeferred Income Tax Liabilities, Net ($M) ($M)Year on yearSource
FY2025Dec 31, 202553.2+26.7%Form 10-Q (filed 2026-08-05) ↗
FY2024Dec 31, 202442+154.5%Form 10-K (filed 2026-02-26) ↗
FY2023Dec 31, 202316.5+3.1%Form 10-K (filed 2025-02-27) ↗
FY2022Dec 31, 202216+12.7%Form 10-K (filed 2024-02-26) ↗
FY2021Dec 31, 202114.2+31.5%Form 10-K (filed 2023-02-27) ↗
FY2020Dec 31, 202010.8+2.9%Form 10-K (filed 2022-02-28) ↗
FY2019Dec 31, 201910.5-5.4%Form 10-K (filed 2021-02-25) ↗
FY2018Dec 31, 201811.1–Form 10-K (filed 2020-03-02) ↗
FY2017Dec 31, 20170–Form 10-K (filed 2019-02-28) ↗

Cite this data

StockData. (2026). BeOne Medicines Deferred Income Tax Liabilities, Net ($M), annual FY2017–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/dtl-net

See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.